European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
AB Chang, R Fortescue, K Grimwood… - European …, 2021 - Eur Respiratory Soc
There is increasing awareness of bronchiectasis in children and adolescents, a chronic
pulmonary disorder associated with poor quality of life for the child/adolescent and their …
pulmonary disorder associated with poor quality of life for the child/adolescent and their …
[HTML][HTML] Use of corticosteroids in asthma and COPD patients with or without COVID-19
The potential detrimental effects of steroids on the immune system to fight viral infections
had always been a concern for patients on long term steroids in chronic conditions. A recent …
had always been a concern for patients on long term steroids in chronic conditions. A recent …
[HTML][HTML] Inhaled corticosteroids and the pneumonia risk in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
H Chen, J Sun, Q Huang, Y Liu, M Yuan… - Frontiers in …, 2021 - frontiersin.org
Background: Whether all types of inhaled corticosteroids (ICSs) would increase the
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …
Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A …
FS Leitao Filho, H Takiguchi, K Akata… - American journal of …, 2021 - atsjournals.org
Rationale: Inhaled corticosteroids (ICS) are commonly prescribed with long-acting β2-
agonists (LABA) in chronic obstructive pulmonary disease (COPD). To date, the effects of …
agonists (LABA) in chronic obstructive pulmonary disease (COPD). To date, the effects of …
[HTML][HTML] Phosphodiesterase-4 inhibitors for non-COPD respiratory diseases
T Kawamatawong - Frontiers in pharmacology, 2021 - frontiersin.org
Selective phosphodiesterase (PDE) inhibitors are a class of nonsteroid anti-inflammatory
drugs for treating chronic inflammatory diseases. Modulation of systemic and airway …
drugs for treating chronic inflammatory diseases. Modulation of systemic and airway …
[HTML][HTML] Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease
JL Lopez-Campos, M Miravitlles… - Journal of clinical …, 2020 - mdpi.com
Currently, chronic obstructive pulmonary disease (COPD) patients and their physicians face
a number of significant clinical challenges, one of which is the high degree of uncertainty …
a number of significant clinical challenges, one of which is the high degree of uncertainty …
[HTML][HTML] Health-related quality of life and its associated factors in patients with chronic obstructive pulmonary disease
Objective The present study aimed to evaluate HRQOL and to explore the factors associated
with poor HRQOL among patients with COPD. Methods In the present cross-sectional study …
with poor HRQOL among patients with COPD. Methods In the present cross-sectional study …
[HTML][HTML] Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
C Janson - Journal of Thoracic Disease, 2020 - ncbi.nlm.nih.gov
In chronic obstructive pulmonary disease (COPD), treatment with inhaled corticosteroids
(ICSs) in combination with long acting beta-2-agonists (LABA) or LABA/long-acting …
(ICSs) in combination with long acting beta-2-agonists (LABA) or LABA/long-acting …
[HTML][HTML] The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
Background The observation of patients hospitalized for coronavirus disease (COVID-19)
led us to note a lower prevalence of patients affected by chronic respiratory disease, in …
led us to note a lower prevalence of patients affected by chronic respiratory disease, in …
[HTML][HTML] Inhaled corticosteroids selectively alter the microbiome and host transcriptome in the small airways of patients with chronic obstructive pulmonary disease
Background: Patients with chronic obstructive pulmonary disease (COPD) are commonly
treated with inhaled corticosteroid/long-acting ß2-agonist combination therapy. While …
treated with inhaled corticosteroid/long-acting ß2-agonist combination therapy. While …